In this context, it is not surprising that the progression of systemic autoimmune diseases such as systemic lupus erythematosus (SLE) often associates with an increased type I IFN production (13), as IFN levels in SLE patients correlate with autoantibody production (20). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.